nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—CHRM3—Nicardipine—hypertension	0.223	0.374	CbGbCtD
Oxyphencyclimine—CHRM1—Nicardipine—hypertension	0.194	0.326	CbGbCtD
Oxyphencyclimine—CHRM2—Nicardipine—hypertension	0.179	0.3	CbGbCtD
Oxyphencyclimine—CHRM3—Metabolism—ADCY5—hypertension	3.11e-05	7.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3R1—hypertension	3.11e-05	7.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GPX1—hypertension	3.1e-05	7.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT2—hypertension	3.08e-05	7.61e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3R1—hypertension	3.08e-05	7.6e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRB2—hypertension	3.07e-05	7.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PRKCA—hypertension	3.07e-05	7.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CYP1A1—hypertension	3.07e-05	7.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRB2—hypertension	3.06e-05	7.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCE—hypertension	3.03e-05	7.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRB2—hypertension	3.03e-05	7.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCE—hypertension	3.02e-05	7.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CD36—hypertension	3.02e-05	7.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PDGFA—hypertension	2.99e-05	7.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—VAV3—hypertension	2.99e-05	7.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCE—hypertension	2.99e-05	7.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PDGFA—hypertension	2.99e-05	7.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—VAV3—hypertension	2.99e-05	7.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PDGFA—hypertension	2.96e-05	7.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—VAV3—hypertension	2.96e-05	7.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TGFBR2—hypertension	2.95e-05	7.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TGFBR2—hypertension	2.94e-05	7.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNB3—hypertension	2.92e-05	7.23e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNB3—hypertension	2.92e-05	7.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TGFBR2—hypertension	2.91e-05	7.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNB3—hypertension	2.89e-05	7.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AVP—hypertension	2.89e-05	7.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AVP—hypertension	2.88e-05	7.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—RHOA—hypertension	2.86e-05	7.07e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—MTHFR—hypertension	2.86e-05	7.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—RHOA—hypertension	2.85e-05	7.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AVP—hypertension	2.85e-05	7.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNAS—hypertension	2.85e-05	7.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNAS—hypertension	2.84e-05	7.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3R1—hypertension	2.83e-05	6.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—RHOA—hypertension	2.82e-05	6.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3R1—hypertension	2.82e-05	6.97e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNAS—hypertension	2.81e-05	6.95e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARA—hypertension	2.8e-05	6.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3R1—hypertension	2.79e-05	6.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOB—hypertension	2.79e-05	6.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOB—hypertension	2.78e-05	6.87e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PTK2—hypertension	2.78e-05	6.86e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PTK2—hypertension	2.77e-05	6.84e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CXCL8—hypertension	2.76e-05	6.83e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CXCL8—hypertension	2.76e-05	6.81e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOB—hypertension	2.75e-05	6.8e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EDN1—hypertension	2.74e-05	6.78e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PTK2—hypertension	2.74e-05	6.77e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EDN1—hypertension	2.74e-05	6.76e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CXCL8—hypertension	2.73e-05	6.74e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL5—hypertension	2.72e-05	6.73e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AGT—hypertension	2.72e-05	6.71e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL5—hypertension	2.71e-05	6.71e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EDN1—hypertension	2.71e-05	6.69e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL5—hypertension	2.69e-05	6.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CALM1—hypertension	2.67e-05	6.6e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LPL—hypertension	2.66e-05	6.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOE—hypertension	2.66e-05	6.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LPL—hypertension	2.65e-05	6.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—H2AFX—hypertension	2.64e-05	6.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RPS6KB1—hypertension	2.64e-05	6.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PDGFRB—hypertension	2.64e-05	6.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CAV1—hypertension	2.64e-05	6.51e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—H2AFX—hypertension	2.64e-05	6.51e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RPS6KB1—hypertension	2.63e-05	6.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PDGFRB—hypertension	2.63e-05	6.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOA1—hypertension	2.63e-05	6.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LPL—hypertension	2.63e-05	6.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—H2AFX—hypertension	2.61e-05	6.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADCY5—hypertension	2.61e-05	6.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PDGFRB—hypertension	2.6e-05	6.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RPS6KB1—hypertension	2.6e-05	6.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADCY5—hypertension	2.6e-05	6.42e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCG—hypertension	2.59e-05	6.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCG—hypertension	2.58e-05	6.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADCY5—hypertension	2.57e-05	6.36e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ITGB3—hypertension	2.57e-05	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCA—hypertension	2.57e-05	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCA—hypertension	2.56e-05	6.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ITGB3—hypertension	2.56e-05	6.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCG—hypertension	2.56e-05	6.32e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—YWHAZ—hypertension	2.55e-05	6.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—YWHAZ—hypertension	2.54e-05	6.28e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCA—hypertension	2.54e-05	6.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ITGB3—hypertension	2.54e-05	6.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SPP1—hypertension	2.52e-05	6.23e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NGF—hypertension	2.52e-05	6.23e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—YWHAZ—hypertension	2.52e-05	6.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NGF—hypertension	2.51e-05	6.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SPP1—hypertension	2.51e-05	6.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CXCL8—hypertension	2.51e-05	6.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CXCL8—hypertension	2.5e-05	6.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SPP1—hypertension	2.49e-05	6.15e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NGF—hypertension	2.49e-05	6.15e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CXCL8—hypertension	2.48e-05	6.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCR5—hypertension	2.45e-05	6.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCD—hypertension	2.45e-05	6.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCR5—hypertension	2.45e-05	6.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCD—hypertension	2.45e-05	6.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCR5—hypertension	2.42e-05	5.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCD—hypertension	2.42e-05	5.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR2A—hypertension	2.4e-05	5.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—C3—hypertension	2.4e-05	5.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR2A—hypertension	2.39e-05	5.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—C3—hypertension	2.39e-05	5.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR2A—hypertension	2.37e-05	5.86e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—C3—hypertension	2.37e-05	5.85e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PDGFB—hypertension	2.33e-05	5.77e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PDGFB—hypertension	2.33e-05	5.75e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FGFR1—hypertension	2.32e-05	5.74e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARG—hypertension	2.32e-05	5.73e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FGFR1—hypertension	2.31e-05	5.72e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PDGFB—hypertension	2.3e-05	5.69e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FGFR1—hypertension	2.29e-05	5.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HIF1A—hypertension	2.29e-05	5.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—POMC—hypertension	2.29e-05	5.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HIF1A—hypertension	2.28e-05	5.63e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGT—hypertension	2.28e-05	5.63e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—INS—hypertension	2.27e-05	5.62e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGT—hypertension	2.27e-05	5.61e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HIF1A—hypertension	2.26e-05	5.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGT—hypertension	2.25e-05	5.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CALM1—hypertension	2.24e-05	5.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CALM1—hypertension	2.23e-05	5.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LEP—hypertension	2.23e-05	5.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOE—hypertension	2.23e-05	5.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LEP—hypertension	2.22e-05	5.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOE—hypertension	2.22e-05	5.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CAV1—hypertension	2.21e-05	5.46e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CALM1—hypertension	2.21e-05	5.46e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOA1—hypertension	2.21e-05	5.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CAV1—hypertension	2.2e-05	5.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LEP—hypertension	2.2e-05	5.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOE—hypertension	2.2e-05	5.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOA1—hypertension	2.2e-05	5.43e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KDR—hypertension	2.19e-05	5.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CAV1—hypertension	2.18e-05	5.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KDR—hypertension	2.18e-05	5.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOA1—hypertension	2.18e-05	5.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KDR—hypertension	2.16e-05	5.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—F2—hypertension	2.1e-05	5.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCB—hypertension	2.1e-05	5.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FN1—hypertension	2.1e-05	5.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—F2—hypertension	2.1e-05	5.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FN1—hypertension	2.1e-05	5.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCB—hypertension	2.1e-05	5.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ALB—hypertension	2.08e-05	5.15e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FN1—hypertension	2.08e-05	5.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—F2—hypertension	2.08e-05	5.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCB—hypertension	2.08e-05	5.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NOTCH1—hypertension	2.06e-05	5.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NOTCH1—hypertension	2.05e-05	5.07e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NOTCH1—hypertension	2.03e-05	5.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—NOS3—hypertension	1.99e-05	4.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3R1—hypertension	1.99e-05	4.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—POMC—hypertension	1.92e-05	4.74e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—POMC—hypertension	1.91e-05	4.72e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—INS—hypertension	1.91e-05	4.71e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—INS—hypertension	1.9e-05	4.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—POMC—hypertension	1.89e-05	4.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—INS—hypertension	1.88e-05	4.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL2—hypertension	1.88e-05	4.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL2—hypertension	1.87e-05	4.62e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL2—hypertension	1.85e-05	4.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF1—hypertension	1.84e-05	4.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT2—hypertension	1.84e-05	4.55e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF1—hypertension	1.84e-05	4.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT2—hypertension	1.84e-05	4.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—EGFR—hypertension	1.84e-05	4.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—EGFR—hypertension	1.83e-05	4.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTGS2—hypertension	1.82e-05	4.51e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF1—hypertension	1.82e-05	4.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT2—hypertension	1.82e-05	4.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—EGFR—hypertension	1.81e-05	4.48e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SERPINE1—hypertension	1.75e-05	4.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SERPINE1—hypertension	1.75e-05	4.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SERPINE1—hypertension	1.73e-05	4.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FGF2—hypertension	1.7e-05	4.19e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FGF2—hypertension	1.69e-05	4.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RHOA—hypertension	1.69e-05	4.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RHOA—hypertension	1.68e-05	4.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FGF2—hypertension	1.67e-05	4.14e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3R1—hypertension	1.67e-05	4.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NOS3—hypertension	1.67e-05	4.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RHOA—hypertension	1.67e-05	4.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NOS3—hypertension	1.67e-05	4.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3R1—hypertension	1.67e-05	4.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3R1—hypertension	1.65e-05	4.08e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NOS3—hypertension	1.65e-05	4.08e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTEN—hypertension	1.59e-05	3.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RELA—hypertension	1.57e-05	3.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RELA—hypertension	1.57e-05	3.88e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RELA—hypertension	1.55e-05	3.84e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MTOR—hypertension	1.54e-05	3.81e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MTOR—hypertension	1.54e-05	3.8e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MTOR—hypertension	1.52e-05	3.77e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—EP300—hypertension	1.52e-05	3.75e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL8—hypertension	1.48e-05	3.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL8—hypertension	1.48e-05	3.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL8—hypertension	1.46e-05	3.62e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AKT1—hypertension	1.43e-05	3.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AKT1—hypertension	1.43e-05	3.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AKT1—hypertension	1.41e-05	3.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—IL6—hypertension	1.41e-05	3.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—IL6—hypertension	1.41e-05	3.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—IL6—hypertension	1.39e-05	3.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MMP9—hypertension	1.34e-05	3.32e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MMP9—hypertension	1.34e-05	3.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CDKN1A—hypertension	1.34e-05	3.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PTEN—hypertension	1.33e-05	3.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CDKN1A—hypertension	1.33e-05	3.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PTEN—hypertension	1.33e-05	3.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MMP9—hypertension	1.32e-05	3.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CDKN1A—hypertension	1.32e-05	3.26e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PTEN—hypertension	1.32e-05	3.25e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MAPK8—hypertension	1.3e-05	3.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AKT1—hypertension	1.3e-05	3.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MAPK8—hypertension	1.3e-05	3.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AKT1—hypertension	1.3e-05	3.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MAPK8—hypertension	1.29e-05	3.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT1—hypertension	1.28e-05	3.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EP300—hypertension	1.27e-05	3.14e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EP300—hypertension	1.27e-05	3.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EP300—hypertension	1.26e-05	3.1e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SRC—hypertension	1.24e-05	3.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SRC—hypertension	1.23e-05	3.05e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SRC—hypertension	1.22e-05	3.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—VEGFA—hypertension	1.2e-05	2.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—VEGFA—hypertension	1.2e-05	2.97e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—VEGFA—hypertension	1.19e-05	2.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MYC—hypertension	1.11e-05	2.74e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TGFB1—hypertension	1.11e-05	2.73e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MYC—hypertension	1.1e-05	2.73e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TGFB1—hypertension	1.1e-05	2.72e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MYC—hypertension	1.09e-05	2.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TGFB1—hypertension	1.09e-05	2.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EGFR—hypertension	1.08e-05	2.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EGFR—hypertension	1.08e-05	2.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EGFR—hypertension	1.07e-05	2.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AKT1—hypertension	9.16e-06	2.26e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TP53—hypertension	9.1e-06	2.25e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TP53—hypertension	9.07e-06	2.24e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TP53—hypertension	8.99e-06	2.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6—hypertension	8.33e-06	2.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6—hypertension	8.31e-06	2.05e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6—hypertension	8.22e-06	2.03e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT1—hypertension	7.69e-06	1.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT1—hypertension	7.66e-06	1.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT1—hypertension	7.59e-06	1.87e-05	CbGpPWpGaD
